MapLight Therapeutics (MPLT) Total Liabilities (2024 - 2025)
MapLight Therapeutics (MPLT) reported Total Liabilities of $21.1 million for Q4 2025, down 2.67% on a YoY basis from $21.7 million in Q4 2024, and down 10.82% sequentially from $23.7 million in Q3 2025.
MapLight Therapeutics (MPLT) Total Liabilities (2024 - 2025) Analysis & Trends
MapLight Therapeutics (MPLT) has 2 years of Total Liabilities data on file, last reported at $21.1 million in Q4 2025.
- For the quarter ending Q4 2025, Total Liabilities fell 2.67% year-over-year to $21.1 million; the trailing twelve-month figure through Dec 2025 stood at $21.1 million (down 2.67% YoY), and the FY2025 full-year result was $21.1 million, down 2.67% from the prior year.
- Total Liabilities slipped to $21.1 million in Q4 2025, from $23.7 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $23.7 million in Q3 2025 to a low of $21.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 177.22 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 7.33 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.62 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 753.82 Mn |
| 10 | MapLight Therapeutics | 305.82 Mn | 305.82 Mn | - | 21.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.14 Mn |
| Sep 30, 2025 | 23.71 Mn |
| Dec 31, 2024 | 21.72 Mn |